MML INVESTORS SERVICES, LLC
Position in ESPR — Esperion Therapeutics, Inc.
CIK 701059
SPRINGFIELD, MA
Position in ESPR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$0
+$0 QoQ
Shares Held
21,450
-0.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MML INVESTORS SERVICES, LLC holds $17,637,641 across 15 Drug Manufacturers - Specialty & Generic names. ESPR ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
45,009 | $3,234,346 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
79,705 | $2,700,405 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
13,856 | $2,335,290 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
3,515 | $1,904,532 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
107,857 | $1,867,004 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
96,887 | $1,553,098 | |
| 7 | HLN |
Haleon plc
|
138,185 | $1,289,266 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
29,616 | $728,849 |
All Filings in ESPR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 21,450 | Shares | Defined | 2026-08-07 | |
| 2025-12-31 | — | 21,511 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | — | 23,078 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | — | 22,748 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | — | 17,153 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | — | 12,791 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | — | 12,378 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | — | 12,047 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||